**Core Concept**
Von Hippel-Lindau (VHL) syndrome is a genetic disorder characterized by the development of multiple hemangioblastomas and other tumors, including renal cell carcinoma, pheochromocytoma, and retinal angiomas. The syndrome is caused by mutations in the VHL gene, which is a tumor suppressor gene that regulates the activity of hypoxia-inducible factors (HIFs).

**Why the Correct Answer is Right**
The correct answer is related to the high incidence of hemangioblastomas in the central nervous system (CNS) of patients with VHL syndrome. Hemangioblastomas are benign tumors that arise from the endothelial cells of blood vessels. They are typically found in the cerebellum, spinal cord, and retina. The development of hemangioblastomas in VHL syndrome is thought to be due to the inactivation of the VHL gene, which leads to the accumulation of HIFs and the activation of angiogenic pathways.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because VHL syndrome is not commonly associated with glioblastoma, a type of malignant brain tumor.
* **Option B:** This option is incorrect because neurofibromatosis type 1 (NF1) is a different genetic disorder that is characterized by the development of neurofibromas and other tumors, but it is not associated with hemangioblastomas.
* **Option D:** This option is incorrect because medulloblastoma is a type of malignant brain tumor that is more commonly seen in children, and it is not typically associated with VHL syndrome.

**Clinical Pearl / High-Yield Fact**
Hemangioblastomas in VHL syndrome can cause symptoms such as headache, visual disturbances, and ataxia due to their location in the CNS. They are often diagnosed incidentally on imaging studies, and treatment typically involves surgical resection.

**Correct Answer:** C. Hemangioblastoma.